MedTrace Logo

Comparison of DNS-Based Developmental Exercise and Single Leg Squat Exercise in Fencers

NCT07252635 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-11-28

No results posted yet for this study

Summary

The goal of this clinical trial is to learn how three different exercises affect quadriceps muscle activity (Vastus medialis, Vastus lateralis, and Rectus femoris) in young fencers. The three exercises are: a single-leg decline squat, a single-leg decline squat with core activation, and a half high-kneeling exercise based on Dynamic Neuromuscular Stabilization (DNS).

The main question it aims to answer is:

* Which of these three exercises produces the highest activity in the quadriceps muscles (Vastus medialis, Vastus lateralis, and Rectus femoris)?
* Researchers will compare all three exercises to see which one best activates the quadriceps muscles.

Participants will:

* Perform all three exercises in a random order
* Have sensors (surface EMG) placed on the Vastus medialis, Vastus lateralis, and Rectus femoris muscles to record activity
* Complete each exercise with standardized timing

This information may help guide training and injury prevention programs for fencing athletes by identifying which exercises most effectively activate the quadriceps muscles.

Conditions

  • Quadriceps Muscle

Interventions

OTHER

EMG analysis during Single-Leg Decline Squat

EMG analysis during Half high kneeling exercise

Sponsors & Collaborators

  • Gazi University

    collaborator OTHER

  • Saglik Bilimleri Universitesi

    lead OTHER

Principal Investigators

  • Seda Bicici Ulusahin, PT PhD · Saglik Bilimleri Universitesi

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-05
Primary Completion
2025-08-01
Completion
2025-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07252635 on ClinicalTrials.gov